throbber
8/1/2017
`
`JUBL|A® (efinaconazole): For the treatment of toenail fungus
`
`Prescribin Information htt
`
`://www.vaIeant.com/Portals/ZS/Pdf/Pl/Juina-PI. df
`
`lm ortant Safe
`
`Information /im ortant-safe -information
`
`For Health Care Professionals(lhcp)
`
`MENU
`
`ABOUT TOENAIL FUNGUS (HTTP:INVWW.JUBLIARX.COMIABOUT-TOENAIL-
`FUNGUS)
`
`USING JUBLIA (HTTP:IIWWW.JUBLIARX.COMIUSING-JUBLIA)
`
`EFFICACY & SIDE EFFECTS (HTTP:INVWW.JUBLIARX.COMIEFFICACY—
`SIDE-EFFECTS)
`
`IS JUBLIA RIGHT FOR ME? (HTTP:IIWWW.JUBLIARX.COMISCREENER)
`
`FAQS (HTTP:/NVWW.JUBLIARX.COM/FAQS)
`
`UPSTAGED BY
`
`FIGHT IT
`
`WITH JUBLIA
`
`An FDA-approved prescription topical solution
`proven to treat toenail fungus (onychomycosis).—
`
`Instant Savings Offer*
`
`at Walgreens and other participating independent pharmacies
`
`Start Saving
`
`"'
`
`".
`
`"'"""'"——
`
`(http://www.valeantaccessprogram.com/)
`
`Before & After
`
`Individual results may vary.
`A See More
`
`See JUBLIA Results
`
`IMPORTANT SAFETY INFORMATION
`- JUBLIA is for use on nails and surrounding skin only. Do not use
`
`JUBLIA in your mo th, elyes,‘or vagina. IUFe it exactly as instructed by
`_El—I‘
`I
`‘
`|
`__". uflur doctor.
`’-
`
`http://www.jub|iarx.com/
`
`1/3
`
`Page 1 of 3
`
`Kaken Exhibit 2091
`
`Acrux V. Kaken
`
`IPR2017-0019O
`
`

`

`8/1/2017
`
`JUBL|A® (efinaconazole): For the treatment of toenail fungus
`
`
`
`JUBLIA fights toenail fungus at the site of infection.
`
`See How
`
`
`
`(lusing-jublia)
`INDICATION
`JUBLIA (efinaconazole) Topical Solution, 10% is a prescription medicine used to treat fungal infections of
`the toenails.
`
`IMPORTANT SAFETY INFORMATION
`' JUBLIA is for use on nails and surrounding skin only. Do not use JUBLIA in your mouth, eyes, or vagina.
`Use it exactly as instructed by your doctor.
`0 It is not known whether JUBLIA is effective in children.
`- Before you use JUBLIA, tell your doctor about all your medical conditions, including if you are or plan to
`become pregnant, are breastfeeding, or plan to breastfeed, because it is not known whether JUBLIA can
`harm an unborn fetus or nursing infant. Tell your doctor about all medications you are taking, and whether
`you have any other nail infections.
`0 JUBLIA is flammable. Avoid heat and flame while applying JUBLIA to your toenail.
`o JUBLIA may cause irritation at the treated site. The most common side effects include: ingrown toenail,
`redness, itching, swelling, burning or stinging, blisters, and pain. Tell your doctor about any side effects
`that bother you or do not go away.
`
`You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
`www.fda.gov/medwatch Ihttp://www.fda.gov/medwatchI or call 1-800-FDA-1088.
`
`Click here for Prescribing Information, including Patient Information.
`htt
`://www.valeant.com/Portals/25/Pdf/PI/Jublia-P|. df
`
`*This offer is only valid for patients with commercial insurance.Eligible uninsured patients will pay more.This
`offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any
`federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare
`Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of
`Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other
`federal or state health care programs. This offer is good only in the U.S. at retail pharmacies owned and
`operated by Walgreen Co. (or its affiliates) or other participating independent retail pharmacies. This offer
`is not valid in Massachusetts or Minnesota or where otherwise prohibited, taxed or othenNise restricted.
`Click here Ihttp://www.valeantaccessprogram.com/) for other terms and conditions that apply.
`
`© 2017 Valeant Pharmaceuticals North America LLC JUB.OO15.USA.17
`
`Important Safeg Information (Iimgonant—safety—information1 Contact Us (httg://www.valeant.com/about/contact-usI
`Privacy PolicyIhttp://www.vaIeant.com/privacy.aspxI
`Legal Notice http://www.valeant.com/terms.asgxI
`Site Map lsitemapl
`
`http://www.jubliarx.com/
`
`Page 2 of 3
`
`2/3
`
`

`

`8/1 /201 7
`
`JUBLIA® (efinaconazole): For the treatment of toenail fungus
`
`http://www.jubliarx.com/
`
`3/3
`
`Page 3 of 3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket